Insight

Jan 21, 2025, 14:12

Myeloma Paper of the Day, January 21st, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Proteasome inhibition enhances oncolytic reovirus therapy in myeloma independently of its direct cytotoxic effects via immune activation and killing of myeloma.”

“Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects”

Authors: Ada Alice Dona, Theophilus Tandoh, Douglas Sborov, Flavia Pichiorri, Craig Hofmeister et al.

More posts featuring Robert Orlowski.

Ada Alice Dona cancer Craig Hofmeister Douglas Sborov Flavia Pichiorri MM multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Theophilus Tandoh

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

Karen Knudsen: Clinical trials are the most advanced form of cancer care

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results